abstract |
The present invention is directed to chromenone compounds of formula (II), pharmaceutically acceptable salts, solvates thereof, and the composition comprising the compounds or the like. They can be used to modulating the function of estrogen receptor ER-.alpha.36 preventing and/or treating the estrogen related diseases, such as breast cancer, leukemia, and liver cancer. |